SFES SafeStitch Medical, Inc. featured news, full reports, and detailed charts
SafeStitch Medical, Inc. (SFES/SFES.OB) Wrap Up:
SafeStitch Medical, Inc., a development stage medical device company, focuses on the development and sale of medical devices. The company’s medical devices manipulate tissues for obesity, gastroesophageal reflux disease (GERD), Barrett’s Esophagus, esophageal obstructions, upper gastrointestinal bleeding, hernia formation, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery. Its products include intraluminal gastroplasty device for obesity and GERD; Barrett’s excision and ablation device for treatment and diagnosis of Barrett’s Esophagus; Smart Dilator, which is used to expand the esophagus; Standard Bite Block that is used to protect the endoscope used ...SafeStitch Medical, Inc. (SFES:OTC Bulletin Board Market)
Snapshot of SafeStitch Medical, Inc. (SFES)
|
OPEN
$1.01
|
PREVIOUS CLOSE
$1.01
|
|
|
DAY HIGH
$1.01
|
DAY LOW
$1.00
|
|
|
52 WEEK HIGH
11/25/08 - $1.50
|
52 WEEK LOW
03/17/09 - $0.45
|
|
|
MARKET CAP
18.0M
|
AVERAGE VOLUME 3 mo
678.0
|
|
|
DILUTED EPS TTM
$-0.22
|
SHARES OUTSTANDING
18.0M
|
|
|
SFES Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
SFES Top Compensated Officers
Executives, Board Directors
Key developments for SafeStitch Medical, Inc. (SFES)
SafeStitch Medical, Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration ('FDA') to market its AMID StaplerTM in the U.S. with the intended use in general surgery procedures for fixation of mesh, in the repair of hernia defects and in other surgical specialties for the approximation of tissues, including skin. The AMID Stapler(TM) is the first surgical stapler designed specifically for use in inguinal hernia repairs using the Lichtenstein method, in which mesh is implanted to reinforce the groin floor.
On September 24, 2009, the Board of Directors of SafeStitch Medical Inc. appointed Dr. Chao C. Chen to fill a vacancy on the Board. Mr. Chen will serve until the next annual meeting of the company's stockholders or until his earlier death, resignation or removal. Chao C. Chen, Ph.D., age 56, has served since May 2009 as Chief Operating Officer of UniMed VM, a Taiwanese investment company. From September 2008 to May 2009, Dr. Chen served as Vice President of TaiMed Inc., where he was responsible for medical technology investments.
To provide a review of recent corporate developments
SFES Competitors
| Company | Last | Change | |
| No competitor information is available for SFES. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | SFES | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
|
SFES |
||
SFES transactions
| Type Date |
Target |
|
Private Placement
July 21, 2009 |
-- |